NewzRene Haas, chief executive of Cambridge-based Arm Holdings—described as the UK's biggest tech firm—stated that artificial intelligence will find a cure for cancer that humans cannot achieve within our lifetimes. According to the executive, the development of these AI-driven medical breakthroughs is currently being slowed by a shortage of semiconductor chips.
Elaborating on the technical hurdles, Haas noted that computers are ultimately going to solve the problem, though modeling how a DNA marker is specifically impacted by cancer is not something that can be accomplished at the present time due to these hardware limitations.
In-depth summary · AI, neutral